Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Transcript
Pyxis Oncology, Inc. (PYXS) Discusses Preliminary Phase 1 Data for MICVO in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma - Slideshow (NASDAQ:PYXS) 2025-12-18
Nasdaq Gains Over 200 Points; US Inflation Slows To 2.7% - Actelis Networks (NASDAQ:ASNS), Athira Pharma (NASDAQ:ATHA)
Dow Surges 400 Points; Accenture Earnings Top Views - Accenture (NYSE:ACN), Actelis Networks (NASDAQ:ASNS)